Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome

Maria Laura Stromillo1, Antonio Giorgio, Francesca Rossi

  • 1Department of Neurological and Behavioral Sciences, University of Siena, Siena, Italy.

Neurology
|May 3, 2013
PubMed
Abstract

Insights

Radiologically isolated syndrome (RIS) patients show decreased brain N-acetylaspartate (NAA) levels, indicating axonal damage. This finding aids in identifying individuals at high risk for multiple sclerosis (MS) progression.

Area of Science:

  • Neuroimaging
  • Neurology
  • Biochemistry

Background:

  • Radiologically isolated syndrome (RIS) involves white matter (WM) changes on MRI in asymptomatic individuals, meeting criteria for multiple sclerosis (MS).
  • RIS requires further definition for accurate risk stratification of affected subjects.
  • Brain proton magnetic resonance spectroscopic imaging (1H-MRSI) was employed to investigate metabolic alterations in RIS.

Purpose of the Study:

  • To assess metabolic changes in the brain of individuals with radiologically isolated syndrome (RIS) using 1H-MRSI.
  • To compare metabolic profiles of RIS subjects with healthy controls (HC).

Main Methods:

  • Twenty-three RIS subjects (Okuda Criteria) and 20 healthy controls (HC) underwent 1H-MRSI.
  • N-acetylaspartate (NAA) and choline (Cho) levels, normalized to creatine (Cr), were measured in various brain regions (whole central brain (CB)-VOI, lesional/perilesional WM, normal-appearing WM, cortical gray matter (CGM)).

Main Results:

  • RIS subjects exhibited significantly lower NAA/Cr levels compared to HC across all measured brain regions (p < 0.005).
  • No significant differences in Cho/Cr levels were observed between RIS and HC groups.
  • Individual analysis revealed that 44% of RIS subjects had NAA/Cr levels at least 2 standard deviations below the HC mean in normal-appearing WM, and 61% in CGM.

Conclusions:

  • Reduced NAA/Cr levels in RIS subjects suggest significant metabolic abnormalities indicative of axonal damage, even in early stages.
  • These metabolic findings can assist in stratifying RIS individuals based on their risk of progressing to MS.